BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 16807664)

  • 1. Arsenic carcinogenesis in the skin.
    Yu HS; Liao WT; Chai CY
    J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
    Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
    Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects and interactions of low doses of arsenic and UVB on keratinocyte apoptosis.
    Lee CH; Yu CL; Liao WT; Kao YH; Chai CY; Chen GS; Yu HS
    Chem Res Toxicol; 2004 Sep; 17(9):1199-205. PubMed ID: 15377153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Apoptosis, UV-radiation, precancerosis and skin tumors].
    Tomas D
    Acta Med Croatica; 2009 Oct; 63 Suppl 2():53-8. PubMed ID: 19999548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
    Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
    Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer.
    Yu S; Liao WT; Lee CH; Chai CY; Yu CL; Yu HS
    J Dermatol; 2018 Nov; 45(11):1271-1277. PubMed ID: 30144155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arsenic and UVB on normal human cultured keratinocytes: impact on apoptosis and implication on photocarcinogenesis.
    Chen PH; Lan CC; Chiou MH; Hsieh MC; Chen GS
    Chem Res Toxicol; 2005 Feb; 18(2):139-44. PubMed ID: 15720117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant immune responses in arsenical skin cancers.
    Lee CH; Liao WT; Yu HS
    Kaohsiung J Med Sci; 2011 Sep; 27(9):396-401. PubMed ID: 21914527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porocarcinoma in a patient with chronic arsenism and multiple Bowen's disease: case report.
    Chen IS; Kuo HW; Eng HL
    Dermatol Surg; 2005 Sep; 31(9 Pt 1):1149-51. PubMed ID: 16164868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infrequent p53 mutations in arsenic-related skin lesions.
    Castrén K; Ranki A; Welsh JA; Vähäkangas KH
    Oncol Res; 1998; 10(9):475-82. PubMed ID: 10223623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wavelength dependent responses of primary human keratinocytes to combined treatment with benzo[a]pyrene and UV light.
    Crallan RA; Ingham E; Routledge MN
    Mutagenesis; 2005 Jul; 20(4):305-10. PubMed ID: 15956040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low concentrations of formaldehyde induce DNA damage and delay DNA repair after UV irradiation in human skin cells.
    Emri G; Schaefer D; Held B; Herbst C; Zieger W; Horkay I; Bayerl C
    Exp Dermatol; 2004 May; 13(5):305-15. PubMed ID: 15140021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
    Perrem K; Lynch A; Conneely M; Wahlberg H; Murphy G; Leader M; Kay E
    Hum Pathol; 2007 Feb; 38(2):351-8. PubMed ID: 17134737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic-induced mitochondrial instability leading to programmed cell death in the exposed individuals.
    Banerjee N; Banerjee M; Ganguly S; Bandyopadhyay S; Das JK; Bandyopadhay A; Chatterjee M; Giri AK
    Toxicology; 2008 Apr; 246(2-3):101-11. PubMed ID: 18304716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Occupational chronic arsenical poisoning. On the cutaneous manifestations (author's transl)].
    Hamada T; Horiguchi S
    Sangyo Igaku; 1976 Mar; 18(2):103-15. PubMed ID: 1035665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent cellular responses of arsenic in keratinocytes.
    Liao WT; Lan CC; Lee CH; Yu HS
    Kaohsiung J Med Sci; 2011 Sep; 27(9):390-5. PubMed ID: 21914526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
    Luo JL; Tong WM; Yoon JH; Hergenhahn M; Koomagi R; Yang Q; Galendo D; Pfeifer GP; Wang ZQ; Hollstein M
    Cancer Res; 2001 Nov; 61(22):8158-63. PubMed ID: 11719445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy.
    Hsu LI; Chen GS; Lee CH; Yang TY; Chen YH; Wang YH; Hsueh YM; Chiou HY; Wu MM; Chen CJ
    Am J Epidemiol; 2013 Feb; 177(3):202-12. PubMed ID: 23299695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.